Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of DHA on Cognitive Functions in the Elderly
NCT00278135 is registered in ClinicalTrials.gov with dsm-firmenich Switzerland AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of DHA on Cognitive Functions in the Elderly
- Lead sponsor
- dsm-firmenich Switzerland AG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- December 31, 2008
- Enrollment
- 485 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
age-related cognitive decline, age-related memory disorders